ALECTOR

alector-logo

Alector is combining state-of-the-art antibody technology and recent discoveries in neuroimmunology and human genetics to develop novel therapeutics for Alzheimer’s disease, other forms of dementia, and mechanistically related neurodegenerative disorders. Alector’s strategy is to efficiently generate and validate antibody drugs with unique functional properties that engage key disease-altering targets. This approach is enabled by a strategic alliance with Adimab, the industry leader in disco... very and optimization of antibody therapeutics. Alector is currently developing leads for 4 major targets and anticipates taking 2 of these through pre-clinical development and IND enabling studies within 24 months. Alector has incorporated a highly integrated and lean biotechnology structure with extensive outsourcing that supports core scientific and management teams.
#SimilarOrganizations #People #Financial #Website #More

ALECTOR

Social Links:

facebook

Facebook

linkedin

Linkedin

Industry:
Biotechnology Genetics Health Care Therapeutics

Founded:
2013-01-01

Address:
San Francisco, California, United States

Country:
United States

Website Url:
http://www.alector.com

Total Employee:
101+

Status:
Active

Contact:
(415) 231-5660

Email Addresses:
[email protected]

Total Funding:
194.5 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network


Similar Organizations

apton-biosystems-logo

Apton Biosystems

Apton Biosystems develops a high-throughput and low-cost sequencing platform that revolutionizes the availability of genetic analysis.


Current Advisors List

tillman-gerngross_image

Tillman Gerngross Board Chairman @ Alector
Board_member

arnon-rosenthal_image

Arnon Rosenthal Board Member @ Alector
Board_member
2013-01-01

richard-scheller_image

Richard Scheller Board Member @ Alector
Board_member
2018-10-01

carl-l-gordon_image

Carl L. Gordon Board Member @ Alector
Board_member
2013-10-01

terrance-mcguire_image

Terrance McGuire Board Member @ Alector
Board_member
2013-10-01

louis-lavigne_image

Louis Lavigne Board Member @ Alector
Board_member
2018-10-01

david-wehner_image

David Wehner Board Member @ Alector
Board_member
2018-11-01

Current Employees Featured

arnon-rosenthal_image

Arnon Rosenthal
Arnon Rosenthal Founder, President & Chief Executive Officer @ Alector
Founder, President & Chief Executive Officer
2013-05-01

robert-king_image

Robert King
Robert King Chief Development Officer @ Alector
Chief Development Officer
2017-01-01

robert-paul_image

Robert Paul
Robert Paul Chief Medical Officer @ Alector
Chief Medical Officer
2016-10-01

virginia-dejesus-rueff_image

Virginia DeJesus-Rueff
Virginia DeJesus-Rueff VP of Portfolio and Program Management @ Alector
VP of Portfolio and Program Management

marina-roell_image

Marina Roell
Marina Roell Principal Scientist @ Alector
Principal Scientist
2018-10-01

charles-wolfus_image

Charles Wolfus
Charles Wolfus VP of Technology and Digital Health @ Alector
VP of Technology and Digital Health
2019-01-01

herve-rhinn_image

Herve Rhinn
Herve Rhinn Head of Target Discovery and Genomics @ Alector
Head of Target Discovery and Genomics

daniel-maslyar_image

Daniel Maslyar
Daniel Maslyar VP of Clinical Development Oncology @ Alector
VP of Clinical Development Oncology

sabah-oney_image

Sabah Oney
Sabah Oney Chief Business Officer @ Alector
Chief Business Officer
2018-02-01

kristina-vlaovic_image

Kristina Vlaovic
Kristina Vlaovic Vice President of Regulatory Affairs & Pharmacovigilance @ Alector
Vice President of Regulatory Affairs & Pharmacovigilance

Founder


arnon-rosenthal_image

Arnon Rosenthal

asa-abeliovich_image

Asa Abeliovich

tillman-gerngross_image

Tillman Gerngross

Stock Details


Company's stock symbol is NASDAQ:ALEC

Investors List

orbimed-advisors_image

OrbiMed

OrbiMed investment in Series E - Alector

mission-bay-capital-llc_image

Mission Bay Capital

Mission Bay Capital investment in Series E - Alector

euclidean-capital_image

Euclidean Capital

Euclidean Capital investment in Series E - Alector

google-ventures_image

GV

GV investment in Series E - Alector

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series E - Alector

section-32_image

Section 32

Section 32 investment in Series E - Alector

deerfield-management_image

Deerfield Capital Management

Deerfield Capital Management investment in Series E - Alector

amgen-ventures_image

Amgen Ventures

Amgen Ventures investment in Series E - Alector

bioinnovation-capital_image

Mission BioCapital

Mission BioCapital investment in Series E - Alector

casdin-capital_image

Casdin Capital

Casdin Capital investment in Series E - Alector

Investments List

Date Company Article Money raised
2019-02-07 INmuneBIO Alector investment in Post-IPO Equity - INmuneBIO 8.17 M USD

Official Site Inspections

http://www.alector.com Semrush global rank: 3.92 M Semrush visits lastest month: 3.21 K

  • Host name: 23.185.0.3
  • IP address: 23.185.0.3
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Alector" on Search Engine

dfkcompany.com © 2022. All rights reserved